1.The Growth Inhibitory Effect on B16F10 Melanoma Cells by 4-BPCA, an Amide Derivative of Caffeic Acid
YuKyoung PARK ; Shin-Ung KANG ; Jinho LEE ; Byeong-Churl JANG
Keimyung Medical Journal 2022;41(1):17-23
Caffeic acid (CA) is a phenolic compound found naturally in plants and foods. CA and its natural derivatives are reported to have anti-cancer effects on many cancers, including melanoma. (E)-N-(4-Butylphenyl)-3-(3,4-dihydroxyphenyl)acrylamide (4-BPCA) is an amide derivative of CA. Thus far, the anti-cancer effect and mechanism of 4-BPCA in melanoma cells remain unknown. Here we investigated whether 4-BPCA inhibits the growth of B16F10 cells, a mouse melanoma cell line. Of note, treatment of 4-BPCA at 5 M for 24 or 48 h significantly reduced the growth (survival) of B16F10 cells. On mechanistic levels, treatment with 4-BPCA for 24 h led to the activation of caspase-9/3, but not caspase-8, in B16F10 cells. 4-BPCA treatment for 2 or 4 h also decreased the expression levels of myeloid B-cell lymphoma 1 (Mcl-1) in B16F10 cells. However, 4-BPCA treatment for the times tested did not influence the expression levels of X-linked inhibitor of apoptosis protein (XIAP) in B16F10 cells. Of interest, treatment of 4-BPCA for 2 or 4 h greatly reduced the phosphorylation levels of JAK-2 and STAT-5 without altering their total protein expression levels. 4-BPCA also had abilities to increase the expression and phosphorylation levels of glucose-regulated protein-78 (GRP-78) and eukaryotic translation initiation factor-2α (eIF-2α) in B16F10 cells. In summary, these results demonstrate firstly that 4-BPCA has a strong growth-inhibitory effect on B16F10 melanoma cells, mediated via activation of the intrinsic caspase pathway, inhibition of JAK-2 and STAT-5, and triggering endoplasmic reticulum (ER) stress.
2.First Case of Pasteurella multocida Pneumonic Bacteremia in Korea.
Jinho JANG ; Sang Ha KIM ; Gilsung YOO ; Gyu Yel HWANG ; Young UH ; Kap Jun YOON
Annals of Laboratory Medicine 2018;38(5):490-491
No abstract available.
Bacteremia*
;
Korea*
;
Pasteurella multocida*
;
Pasteurella*
4.A Survey of the Use of Antiepileptic Drugs in Stroke Patients.
Jinho LEE ; Wonho JHO ; Pyeong Kang PARK ; Jaehyung KIM ; Wooyoung JANG ; Hyun Young KIM ; Young Seo KIM ; Hee Tae KIM ; Juhan KIM
Journal of the Korean Neurological Association 2013;31(2):101-107
BACKGROUND: Seizures occur in 2-20% of stroke patients. Recent studies have reported that post-stroke seizures are associated with poorer functional outcomesand higher mortality. However there are no official guidelines on how to use antiepileptic drugs (AEDs) in stroke-related seizures. In this study we surveyed neurologists and neurosurgeons and compared the responses of subgroups categorized by department, specialty and workplace discrimination using a questionnaire containing questions concerning the present tendency to use AEDs in stroke patients. METHODS: 256 neurologists and neurosurgeons participated in the survey. The research instrument was a questionnaire comprising 9 parts and 30 questions. The questions concerned stroke mechanism, the prophylactic use of AEDs, and the choice of AED in early and late onset post-stroke seizures. RESULTS: Tendencies to use prophylactic AEDs in stroke differed depending on specialty and workplace(neurologist vs. neurosurgeon; 17.8% vs. 83.1%, p<0.001, hospital vs. university staff; 46.2% vs. 28.4%, p=0.05). The most commonly used prophylactic AEDs were valproic acid (75%) and levetiracetam (60%). Carbamazepine was the most commonly used AED and phenytoin and phenobarbital were still used in all subgroups to treat post-stroke seizures. CONCLUSIONS: There are significant differences between neurologists (17.8%) and neurosurgeons (83.1%) in the use of prophylactic AEDs after stroke. Valproic acid and levetiracetam are considered first-line prophylactic AEDs by neurosurgeon. Phenytoin and phenobarbital are still used in post-stroke seizure although they have been reported to have an adverse influence on motor recovery. We suggest that proper guidelines should be established for the use of AEDs in stroke-related seizures.
Anticonvulsants
;
Carbamazepine
;
Discrimination (Psychology)
;
Humans
;
Phenobarbital
;
Phenytoin
;
Piracetam
;
Surveys and Questionnaires
;
Seizures
;
Stroke
;
Valproic Acid
5.Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4+CD25+Foxp3+ T Cells.
Seong Ok JANG ; Ha Jung KIM ; Young Joon KIM ; Mi Jin KANG ; Ji Won KWON ; Ju Hee SEO ; Hyung Young KIM ; Byoung Ju KIM ; Jinho YU ; Soo Jong HONG
Allergy, Asthma & Immunology Research 2012;4(3):150-156
PURPOSE: Probiotic bacteria can induce immune regulation or immune tolerance in allergic diseases. The underlying mechanisms have been recently investigated, but are still unclear. The aim of this study was to evaluate the protective effects of the probiotic Lactobacillus rhamnosus (Lcr35) in a mouse model of asthma and to identify its mechanism of action. METHODS: Lcr35 was administered daily by the oral route at a dosage of 1x10(9) CFU/mouse in BALB/c mice for 7 days before the first sensitization. Clinical parameters and regulatory T (Treg) cells were examined. The role of CD4+CD25+Foxp3+ Treg cells was analyzed using a Treg cell-depleting anti-CD25 monoclonal antibody (mAb). RESULTS: Airway hyperresponsiveness, total IgE production, pulmonary eosinophilic inflammation, and splenic lymphocyte proliferation were suppressed after Lcr35 treatment. Th1 (IFN-gamma) and Th2 (IL-4, IL-5, and IL-13) cytokines in the serum were suppressed, and the percentage of CD4+CD25+Foxp3+ Treg cells in the spleen was significantly increased in the Lcr35 treatment group. Anti-CD25 mAb administration abolished the protective effects of Lcr35, indicating that CD4+ CD25+Foxp3+ Treg cells are essential in mediating the activity of Lcr35. CONCLUSIONS: Oral administration of Lcr35 attenuated the features of allergic asthma in a mouse model and induced immune regulation by a CD4+CD25+Foxp3+ Treg cell-mediated mechanism.
Administration, Oral
;
Animals
;
Asthma
;
Bacteria
;
Cytokines
;
Eosinophils
;
Immune Tolerance
;
Immunoglobulin E
;
Inflammation
;
Interleukin-5
;
Lactobacillus
;
Lactobacillus rhamnosus
;
Lymphocytes
;
Mice
;
Negotiating
;
Probiotics
;
Spleen
;
T-Lymphocytes
;
T-Lymphocytes, Regulatory
6.Investigation of Filamentous Fungi Producing Safe, Functional Water-Soluble Pigments.
Young Mok HEO ; Kyeongwon KIM ; Sun Lul KWON ; Joorim NA ; Hanbyul LEE ; Seokyoon JANG ; Chul Hwan KIM ; Jinho JUNG ; Jae Jin KIM
Mycobiology 2018;46(3):269-277
The production of water-soluble pigments by fungal strains indigenous to South Korea was investigated to find those that are highly productive in submerged culture. Among 113 candidates, 34 strains that colored the inoculated potato dextrose agar medium were selected. They were cultured in potato dextrose broth and extracted with ethanol. The productivity, functionality (radical-scavenging activities), and color information (CIELAB values) of the pigment extracts were measured. Five species produced intense yellowish pigments, and two produced intense reddish pigments that ranked the highest in terms of absorbance units produced per day. The pigment extracts of Penicillium miczynskii, Sanghuangporus baumii, Trichoderma sp. 1, and Trichoderma afroharzianum exhibited high radical-scavenging activity. However, the S. baumii extract showed moderate toxicity in the acute toxicity test, which limits the industrial application of this pigment. In conclusion, P. miczynskii KUC1721, Trichoderma sp. 1 KUC1716, and T. afroharzianum KUC21213 were the best fungal candidates to be industrial producers of safe, functional water-soluble pigments.
Agar
;
Colorimetry
;
Efficiency
;
Ethanol
;
Fungi*
;
Glucose
;
Korea
;
Penicillium
;
Solanum tuberosum
;
Toxicity Tests, Acute
;
Trichoderma
7.Toxic Inhalational Injury-Associated Interstitial Lung Disease in Children.
Eun LEE ; Ju Hee SEO ; Hyung Young KIM ; Jinho YU ; Won Kyoung JHANG ; Seong Jong PARK ; Ji Won KWON ; Byoung Ju KIM ; Kyung Hyun DO ; Young Ah CHO ; Sun A KIM ; Se Jin JANG ; Soo Jong HONG
Journal of Korean Medical Science 2013;28(6):915-923
Interstitial lung disease in children (chILD) is a group of disorders characterized by lung inflammation and interstitial fibrosis. In the past recent years, we noted an outbreak of child in Korea, which is possibly associated with inhalation toxicity. Here, we report a series of cases involving toxic inhalational injury-associated chILD with bronchiolitis obliterans pattern in Korean children. This study included 16 pediatric patients confirmed by lung biopsy and chest computed tomography, between February 2006 and May 2011 at Asan Medical Center Children's Hospital. The most common presenting symptoms were cough and dyspnea. The median age at presentation was 26 months (range: 12-47 months), with high mortality (44%). Histopathological analysis showed bronchiolar destruction and centrilobular distribution of alveolar destruction by inflammatory and fibroproliferative process with subpleural sparing. Chest computed tomography showed ground-glass opacities and consolidation in the early phase and diffuse centrilobular nodular opacity in the late phase. Air leak with severe respiratory difficulty was associated with poor prognosis. Although respiratory chemicals such as humidifier disinfectants were strongly considered as a cause of this disease, further studies are needed to understand the etiology and pathophysiology of the disease to improve the prognosis and allow early diagnosis and treatment.
APACHE
;
Bronchi/pathology
;
Child, Preschool
;
Cough/etiology
;
Cyclophosphamide/therapeutic use
;
Disinfectants/*toxicity
;
Dyspnea/etiology
;
Enzyme Inhibitors/therapeutic use
;
Humans
;
Hydroxychloroquine/therapeutic use
;
Immunoglobulins/therapeutic use
;
Infant
;
Inhalation
;
Lung Diseases, Interstitial/chemically induced/drug therapy/*pathology
;
Prognosis
;
Retrospective Studies
;
Steroids/therapeutic use
;
Tomography, X-Ray Computed
8.Association of Antioxidants With Allergic Rhinitis in Children From Seoul.
Ju Hee SEO ; Sung Ok KWON ; So Yeon LEE ; Hyung Young KIM ; Ji Won KWON ; Byoung Ju KIM ; Jinho YU ; Hyo Bin KIM ; Woo Kyung KIM ; Gwang Cheon JANG ; Dae Jin SONG ; Jung Yeon SHIM ; Se Young OH ; Soo Jong HONG
Allergy, Asthma & Immunology Research 2013;5(2):81-87
PURPOSE: The prevalence of allergic diseases has risen over the last few decades. Many factors, including environmental factors such as those related to diet, have been considered. Among dietary factors, intake of antioxidant-related nutrients has been associated with the risk of allergic disease. We investigated the association of antioxidant nutritional status with allergic rhinitis (AR) in Korean schoolchildren aged 6-12 years. METHODS: Subjects were 4,554 children in Seoul, Korea. The risk of allergic disease was measured using the Korean version of the International Study of Asthma and Allergies in Childhood, and dietary intake was measured by a semi-quantitative food frequency questionnaire. Intake of vitamins A (including retinol and beta-carotene), C, and E was used in the analysis. RESULTS: Vitamin C intake was negatively associated with an increased risk of current symptoms (adjusted odds ratio, 0.886; 95% confidence interval, 0.806-0.973). There was no association between AR and intake of vitamin A, retinol, beta-carotene, or vitamin E. Total serum IgE level and sensitization to allergen did not differ according to nutrient intake. CONCLUSIONS: The group of children with increased vitamin C consumption had fewer AR symptoms, despite the lack of a difference in total serum IgE level or allergen sensitization. These findings suggest that nutrient intake, especially that of vitamin C, influences AR symptoms.
Aged
;
Antioxidants
;
Ascorbic Acid
;
Asthma
;
beta Carotene
;
Child
;
Diet
;
Humans
;
Hypersensitivity
;
Immunoglobulin E
;
Korea
;
Nutritional Status
;
Odds Ratio
;
Prevalence
;
Rhinitis
;
Rhinitis, Allergic, Perennial
;
Vitamin A
;
Vitamin E
;
Vitamins
;
Surveys and Questionnaires
9.Effects of particulate matter in ambient air on the development and control of asthma.
Sang Heon KIM ; Hyeon Jong YANG ; An Soo JANG ; Sang Hoon KIM ; Woo Jung SONG ; Tae Bum KIM ; Young Min YE ; Young YOO ; Jinho YU ; Jong Seo YOON ; Hye Mi JEE ; Dong In SUH ; Cheol Woo KIM
Allergy, Asthma & Respiratory Disease 2015;3(5):313-319
There has been growing concern regarding the effects of ambient air pollution on asthma. Particulate matter (PM) is one of the major air pollutants affecting both general population and the patients with asthma. This paper reviews the recent evidence of the adverse effects of PM on the inception and morbidity of asthma. Epidemiological studies confirmed that short-term exposure to PM aggravated respiratory symptoms and lung function in asthma patients. Furthermore, PM induces acute exacerbations of asthma with increased risk of hospitalization and death. Long-term exposure to PM is responsible for new onset of asthma and lung function decline in both children and adults. Various mechanisms are involved in the effects of PM on airway including oxidative stress, augmentation of inflammation, promotion of allergen sensitization, induction of airway hyperresponsiveness, aggravation of rhinitis and DNA methylation. Special attention and care is needed for the patients with asthma to prevent the detrimental effects of PM.
Adult
;
Air Pollutants
;
Air Pollution
;
Asthma*
;
Child
;
Disease Progression
;
Disease Susceptibility
;
DNA Methylation
;
Epidemiologic Studies
;
Hospitalization
;
Humans
;
Inflammation
;
Lung
;
Oxidative Stress
;
Particulate Matter*
;
Rhinitis
10.The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model.
Jinho YU ; Seong Ok JANG ; Byoung Ju KIM ; Young Hwa SONG ; Ji Won KWON ; Mi Jin KANG ; Won Ah CHOI ; Hyun Don JUNG ; Soo Jong HONG
Allergy, Asthma & Immunology Research 2010;2(3):199-205
PURPOSE: Lactobacilli are probiotic bacteria that are effective in the management of allergic diseases or gastroenteritis. It is hypothesized that such probiotics have immunoregulatory properties and promote mucosal tolerance. Our goal was to investigate whether Lactobacillus casei rhamnosus Lcr35 could inhibit airway inflammation in an ovalbumin (OVA)-induced murine model of asthma. METHODS: BALB/c mice aged 6 weeks were used in the present study. Lactobacillus casei rhamnosus Lcr35 was administered daily, starting 1 week prior to the first OVA sensitization (group 1) and 2 days before the first 1% OVA airway challenge (group 2). Mice that received only saline at both sensitization and airway challenge time points were used as negative controls (group 3), and those that had OVA-induced asthma were used as positive controls (group 4). Airway responsiveness to methacholine was assessed, and bronchoalveolar lavage (BAL) was performed. At the endpoint of the study, total IgE as well as OVA-specific IgE, IgG1 and IgG2a in serum was measured by enzyme-linked immunosorbent assay. Lung pathology was also evaluated. RESULTS: Airway hyperresponsiveness, total cell counts and the proportion of eosinophils in BAL fluid were significantly decreased in group 1 compared with group 4 (P<0.05). Total serum IgE levels were also significantly decreased in group 1 compared with group 4. Serum levels of OVA-specific IgE, IgG1 and IgG(2a) were not significantly influenced by treatment with Lcr35. There was significantly less peribronchial and perivascular infiltration of inflammatory cells in group 1 compared with group 4; however, there were no significant differences in methacholine challenge, BAL, serology or histology between groups 2 and 4. CONCLUSIONS: Oral treatment with Lcr35 prior to sensitization can attenuate airway inflammation and hyperreactivity in a mouse model of allergic airway inflammation. These results suggest that Lcr35 may have potential for preventing asthma.
Aged
;
Animals
;
Asthma
;
Bacteria
;
Bronchoalveolar Lavage
;
Cell Count
;
Disease Models, Animal
;
Enzyme-Linked Immunosorbent Assay
;
Eosinophils
;
Gastroenteritis
;
Humans
;
Immunoglobulin E
;
Immunoglobulin G
;
Inflammation
;
Lactobacillus
;
Lactobacillus casei
;
Lactobacillus rhamnosus
;
Lung
;
Methacholine Chloride
;
Mice
;
Ovalbumin
;
Ovum
;
Primary Prevention
;
Probiotics